1042 related articles for article (PubMed ID: 10433620)
21. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
22. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
24. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.
Suthers GK
ANZ J Surg; 2007 May; 77(5):314-9. PubMed ID: 17497966
[TBL] [Abstract][Full Text] [Related]
25. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
26. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Mersch J; Jackson MA; Park M; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
Cancer; 2015 Jan; 121(2):269-75. PubMed ID: 25224030
[TBL] [Abstract][Full Text] [Related]
27. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Chen S; Iversen ES; Friebel T; Finkelstein D; Weber BL; Eisen A; Peterson LE; Schildkraut JM; Isaacs C; Peshkin BN; Corio C; Leondaridis L; Tomlinson G; Dutson D; Kerber R; Amos CI; Strong LC; Berry DA; Euhus DM; Parmigiani G
J Clin Oncol; 2006 Feb; 24(6):863-71. PubMed ID: 16484695
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.
Einbeigi Z; Bergman A; Meis-Kindblom JM; Flodin A; Bjursell C; Martinsson T; Kindblom LG; Wahlström J; Wallgren A; Nordling M; Karlsson P
Fam Cancer; 2007; 6(1):35-41. PubMed ID: 16944270
[TBL] [Abstract][Full Text] [Related]
29. Neoplastic diseases in families of breast cancer patients.
Tulinius H; Olafsdottir GH; Sigvaldason H; Tryggvadottir L; Bjarnadottir K
J Med Genet; 1994 Aug; 31(8):618-21. PubMed ID: 7815419
[TBL] [Abstract][Full Text] [Related]
30. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
31. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?
Semple J; Metcalfe KA; Lubinski J; Huzarski T; Gronwald J; Armel S; Lynch HT; Karlan B; Foulkes W; Singer CF; Neuhausen SL; Eng C; Iqbal J; Narod SA;
Breast Cancer Res Treat; 2015 Nov; 154(1):163-9. PubMed ID: 26467043
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Li X; You R; Wang X; Liu C; Xu Z; Zhou J; Yu B; Xu T; Cai H; Zou Q
Clin Cancer Res; 2016 Aug; 22(15):3971-81. PubMed ID: 26979395
[TBL] [Abstract][Full Text] [Related]
33. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
34. Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.
Tea MK; Kroiss R; Muhr D; Fuerhauser-Rappaport C; Oefner P; Wagner TM; Singer CF
Maturitas; 2014 Jan; 77(1):68-72. PubMed ID: 24156927
[TBL] [Abstract][Full Text] [Related]
35. Risk of ovarian cancer and genetic relationship to other cancers in families.
Houlston RS; Bourne TH; Collins WP; Whitehead MI; Campbell S; Slack J
Hum Hered; 1993; 43(2):111-5. PubMed ID: 8359812
[TBL] [Abstract][Full Text] [Related]
36. Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Lee JS; Wacholder S; Struewing JP; McAdams M; Pee D; Brody LC; Tucker MA; Hartge P
J Natl Cancer Inst; 1999 Feb; 91(3):259-63. PubMed ID: 10037104
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
Warner E; Foulkes W; Goodwin P; Meschino W; Blondal J; Paterson C; Ozcelik H; Goss P; Allingham-Hawkins D; Hamel N; Di Prospero L; Contiga V; Serruya C; Klein M; Moslehi R; Honeyford J; Liede A; Glendon G; Brunet JS; Narod S
J Natl Cancer Inst; 1999 Jul; 91(14):1241-7. PubMed ID: 10413426
[TBL] [Abstract][Full Text] [Related]
39. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Meeks HD; Song H; Michailidou K; Bolla MK; Dennis J; Wang Q; Barrowdale D; Frost D; ; McGuffog L; Ellis S; Feng B; Buys SS; Hopper JL; Southey MC; Tesoriero A; ; James PA; Bruinsma F; Campbell IG; ; Broeks A; Schmidt MK; Hogervorst FB; ; Beckman MW; Fasching PA; Fletcher O; Johnson N; Sawyer EJ; Riboli E; Banerjee S; Menon U; Tomlinson I; Burwinkel B; Hamann U; Marme F; Rudolph A; Janavicius R; Tihomirova L; Tung N; Garber J; Cramer D; Terry KL; Poole EM; Tworoger SS; Dorfling CM; van Rensburg EJ; Godwin AK; Guénel P; Truong T; ; Stoppa-Lyonnet D; Damiola F; Mazoyer S; Sinilnikova OM; Isaacs C; Maugard C; Bojesen SE; Flyger H; Gerdes AM; Hansen TV; Jensen A; Kjaer SK; Hogdall C; Hogdall E; Pedersen IS; Thomassen M; Benitez J; González-Neira A; Osorio A; Hoya Mde L; Segura PP; Diez O; Lazaro C; Brunet J; Anton-Culver H; Eunjung L; John EM; Neuhausen SL; Ding YC; Castillo D; Weitzel JN; Ganz PA; Nussbaum RL; Chan SB; Karlan BY; Lester J; Wu A; Gayther S; Ramus SJ; Sieh W; Whittermore AS; Monteiro AN; Phelan CM; Terry MB; Piedmonte M; Offit K; Robson M; Levine D; Moysich KB; Cannioto R; Olson SH; Daly MB; Nathanson KL; Domchek SM; Lu KH; Liang D; Hildebrant MA; Ness R; Modugno F; Pearce L; Goodman MT; Thompson PJ; Brenner H; Butterbach K; Meindl A; Hahnen E; Wappenschmidt B; Brauch H; Brüning T; Blomqvist C; Khan S; Nevanlinna H; Pelttari LM; Aittomäki K; Butzow R; Bogdanova NV; Dörk T; Lindblom A; Margolin S; Rantala J; Kosma VM; Mannermaa A; Lambrechts D; Neven P; Claes KB; Maerken TV; Chang-Claude J; Flesch-Janys D; Heitz F; Varon-Mateeva R; Peterlongo P; Radice P; Viel A; Barile M; Peissel B; Manoukian S; Montagna M; Oliani C; Peixoto A; Teixeira MR; Collavoli A; Hallberg E; Olson JE; Goode EL; Hart SN; Shimelis H; Cunningham JM; Giles GG; Milne RL; Healey S; Tucker K; Haiman CA; Henderson BE; Goldberg MS; Tischkowitz M; Simard J; Soucy P; Eccles DM; Le N; Borresen-Dale AL; Kristensen V; Salvesen HB; Bjorge L; Bandera EV; Risch H; Zheng W; Beeghly-Fadiel A; Cai H; Pylkäs K; Tollenaar RA; Ouweland AM; Andrulis IL; Knight JA; ; Narod S; Devilee P; Winqvist R; Figueroa J; Greene MH; Mai PL; Loud JT; García-Closas M; Schoemaker MJ; Czene K; Darabi H; McNeish I; Siddiquil N; Glasspool R; Kwong A; Park SK; Teo SH; Yoon SY; Matsuo K; Hosono S; Woo YL; Gao YT; Foretova L; Singer CF; Rappaport-Feurhauser C; Friedman E; Laitman Y; Rennert G; Imyanitov EN; Hulick PJ; Olopade OI; Senter L; Olah E; Doherty JA; Schildkraut J; Koppert LB; Kiemeney LA; Massuger LF; Cook LS; Pejovic T; Li J; Borg A; Öfverholm A; Rossing MA; Wentzensen N; Henriksson K; Cox A; Cross SS; Pasini BJ; Shah M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Gronwald J; Agnarsson BA; Kupryjanczyk J; Moes-Sosnowska J; Fostira F; Konstantopoulou I; Slager S; Jones M; ; Antoniou AC; Berchuck A; Swerdlow A; Chenevix-Trench G; Dunning AM; Pharoah PD; Hall P; Easton DF; Couch FJ; Spurdle AB; Goldgar DE
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26586665
[TBL] [Abstract][Full Text] [Related]
40. Cancer risk in relatives of
Liu J; Yao L; Sun J; Hu L; Chen J; Zhang J; Xu Y; Xie Y
Cancer Biol Med; 2023 Mar; 20(2):147-54. PubMed ID: 36861435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
